Can a Wearable Stress Trend Be Compared Across Sessions Without Recalibration?

The research question and what is observable

A wearable device records a higher electrodermal signal on Monday than on Thursday. It may be tempting to conclude that the participant was more stressed on Monday. Yet raw differences between sessions can reflect electrode contact, room conditions, movement and preprocessing choices as well as physiology. The research question is whether a reproducible within-person change remains after measurement conditions have been standardized. A device can faithfully digitize an input while the input itself is sensitive to nonpsychological variation. Calling the whole trace 'stress' imports a psychological interpretation before its validity is established. A market label derived from that interpretation would add still another unsupported inference.

The first methodological obligation is to separate a documented observation from the story attached to it. In this subject, wearable calibration is an operational variable only when its source, time and unit are stated. It should not be used as a synonym for neurofinance methods, because the two describe different layers of inference. A researcher must document when data became available, whether values were revised and which alternative explanations remain plausible. A result that seems persuasive after observing the outcome may not have been predictable beforehand. The goal is to establish a testable and appropriately limited claim, not to manufacture a directional conclusion.

Mechanism and competing explanations

Electrodermal activity is influenced by sympathetic sudomotor processes and is commonly analyzed through slower tonic and faster phasic components. Benedek and Kaernbach studied continuous measures of phasic activity and a decomposition approach [1]. Greco and colleagues' cvxEDA work presents a model-based method for separating signal components [2]. These methods are not interchangeable labels for emotional categories. Different filters and parameter settings can change event counts or amplitudes. If an analyst compares sessions after applying different settings or different placement conditions, a numerical difference may represent the instrument pipeline rather than a stable human characteristic.

Calibration is not the same as normalizing away every inconvenient observation. If a participant genuinely has a stronger response under one task condition, a processing pipeline should preserve that response while accounting for known artifacts. Conversely, standardizing each session to the same scale can erase meaningful between-session variation. Both choices create trade-offs and should be predeclared. Researchers must preserve raw timestamps, record electrode placement and device settings, and keep a log of excluded intervals. A dashboard that displays a smoother trace after processing should not silently imply that the participant has become calmer or more capable of financial judgment.

What the original evidence says

Taylor and colleagues investigated automatic identification of artifacts in electrodermal signals [3], making explicit why activity and recording noise matter. This evidence supports technical quality control, not diagnosis from one trace. Even after a technically valid measurement, two sessions may occur at different times of day or under different task demands. A researcher should distinguish measurement reliability, construct validity and prospective outcome prediction. The fact that a physiological signal can be quantified does not make it a uniquely interpretable measure of fear, much less a predictor of XAU/USD. The NSI framework remains a proposal to test relationships under defined conditions.

Interpretation should also distinguish the scale of the source material from the scale of the proposed use. An experimental study may identify a mechanism under controlled conditions, while an individual's financial decision is affected by changing incentives, competing information and execution constraints. If the objective is research on decision quality, outcomes should include process measures that can be evaluated without knowing whether the trade later won or lost. If the objective is market forecasting, entirely separate point-in-time records and out-of-sample tests are necessary. NSI should report both successful and unsuccessful tests, specify data provenance, and never present a conceptual framework as clinical diagnosis or proven market prediction.

How the hypothesis could be tested fairly

A prospective design would repeat a standardized task across multiple sessions, record environmental and movement covariates, apply a frozen preprocessing pipeline and estimate within-person test-retest properties. Artifacts and missing periods should be reported, not hidden. A second independent task should test whether derived variables track a prespecified behavioral outcome better than simple baseline information. Validation must be performed on unseen sessions so that preprocessing choices are not tuned to the very outcomes used for evaluation. Failure to replicate would narrow the construct claim rather than justify choosing a different filter after the fact.

Conclusion and limits

A changing wearable trace is not self-interpreting. The related articles When a Wrist Sensor Mistakes Movement for Arousal and What Skin Conductance Can and Cannot Reveal About Risk Choices provide necessary foundations. NSI must demonstrate calibration and behavioral validity before any clinical or financial prediction claim.